36 These infants usually respond very well to medical therapy with diazoxide. The diagnosis of hyperinsulinism is based on the clinical presentation and the biochemical markers at the time of ...

Vykat XR is specifically indicated to address hyperphagia, or the abnormally strong sensation of hunger, which often leads to excessive eating. Its approval covers both adult and pediatric patients ...

Although not approved for treating PWS, the parent molecule, diazoxide, treats a few rare diseases in neonates, infants, children and adults. Per the PWS Association USA, approximately one in ...